Trellus Health (TRLS)

Sector:

Health Care

Index:

FTSE AIM All-Share

2.13p
   
  • Change Today:
    -0.13p
  • 52 Week High: 9.20
  • 52 Week Low: 2.13
  • Currency: UK Pounds
  • Shares Issued: 161.51m
  • Volume: 91,579
  • Market Cap: £3.43m

Trellus Health expecting full-year loss in line with expectations

By Josh White

Date: Tuesday 20 Dec 2022

LONDON (ShareCast) - (Sharecast News) - Trellus Health said in an update on Tuesday that for the 2022 period, it was expecting to report that "modest" revenue and an EBITDA loss in line with expectations.
The AIM-traded firm said that at year-end on 31 December, its net cash position was expected to be no less than $18m - slightly better than expected, which the board put down its "close control" of cash.

As it announced in its interim results, and assuming only the level of revenue at that time was maintained, the company said its cash runway was expected to extend into 2025.

Trellus said it would provide a "more detailed" trading update by early February.

Additionally, as it previously announced, Trellus signed two contracts with the Mount Sinai Health System to provide certain patients with access to the Trellus Resilience Training and Self-Management Program for inflammatory bowel disease.

"The first contract will see Mount Sinai make the Trellus IBD program available to, and paid for, as a wellness benefit, to all Mount Sinai Health System employees, focusing initially on inflammatory bowel disease, including Crohn's Disease and ulcerative colitis," the board said in its statement.

"Mount Sinai has a robust employee wellness program which is offered free of charge to all faculty and staff.

"The second contract is to make the Trellus IBD program available, again as a wellness benefit, to eligible patients who are members of a large New York state labour union, which provides health services and benefits to its members through Mount Sinai."

Trellus said that while there was no minimum revenue guarantee under the contracts, the IBD programme was being made available from 1 January as a wellness benefit to eligible participants who had been made aware of the offering.

"These contracts support the company's strategy of rolling out its solution to a wider patient audience.

"The company expects to provide further commentary on its business development opportunities when it issues its further update in early 2023."

At 1231 GMT, shares in Trellus Health were down 8.09% at 10.11p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Trellus Health Market Data

Currency UK Pounds
Share Price 2.13p
Change Today -0.13p
% Change -5.56 %
52 Week High 9.20
52 Week Low 2.13
Volume 91,579
Shares Issued 161.51m
Market Cap £3.43m

Trellus Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.08% above the market average47.08% above the market average47.08% above the market average47.08% above the market average47.08% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
94.29% below the market average94.29% below the market average94.29% below the market average94.29% below the market average94.29% below the market average
78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average
Income Not Available
Growth
23.83% below the market average23.83% below the market average23.83% below the market average23.83% below the market average23.83% below the market average
27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average

Trellus Health Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
12:13 20,000 @ 2.50p
12:06 6,584 @ 2.25p
11:49 6,153 @ 2.22p
11:34 30,000 @ 2.22p
11:18 19,612 @ 2.22p

Trellus Health Key Personnel

CEO Marla Dubinsky

Top of Page